Overall, existing literature suggests that relative corticosteroid-induced immune cell depletion (comparing to other tumors), along with low load of immunogenic molecules, such as MHC II and TLR-4, and a high load of T-suppressive CD 276 interfere with the host’s anti-tumor response. The gene discussed is TLR4; the disease is neoplasm.